Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 255-449-7 | CAS number: 41583-09-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Carcinogenicity
Administrative data
Description of key information
The critical component melamine was administered to rats and mice in a daily diet over a period of 103 weeks (NTP, 1983b, Melnick R.L. et al. 1984a). Due to melamine induced formation of bladder stones leading to bladder tumours, the NOAEL is considered to be 2250 ppm for males (150 mg/kg bw/day) and 4500 ppm for females (300 mg/kg bw/day).
Key value for chemical safety assessment
Justification for classification or non-classification
Dangerous Substance Directive (67/548/EEC)
The available studies are considered reliable and suitable for classification purposes under 67/548/EEC. As a result the substance is not considered to be classified for carcinogenicity under Directive 67/548/EEC, as amended for the 28th time in Directive 2001/59/EC.
Classification, Labelling, and Packaging Regulation (EC) No. 1272/2008
The available experimental test data are reliable and suitable for classification purposes under Regulation 1272/2008. As a result the substance is not considered to be classified for carcinogenicity under Regulation (EC) No. 1272/2008.
Additional information
Reasons for read across
Melamine phosphate was not tested for carcinogenicity. It is acceptable to derive the systemic toxicity from experimental data of melamine since both melamine and its phosphate salt have a high solubility in water and a log POWof less than 1 and phosphate is an abundant in cells and body fluids. Melamine and melamine phosphate have a similar solubility in water (3.5 – 3.9 g/L at 20°C). In addition, the higher molecular weight of melamine phosphate compared to melamine gives a safety margin.
Effects of melamine to urinary bladder
A carcinogenesis bioassay of melamine (NTP, 1983b) was conducted by feeding diets containing 2250 or 4500 ppm melamine to groups of 50 male F344/ N rats and 50 B6C3F, mice of each sex for 103 weeks. Groups of 50 female rats were fed diets containing 4500 or 9000 ppm melamine. Groups of 49 male rats, 50 female rats, 49 male mice, and 50 female mice served as controls.
The predominant effect of melamine in rats was formation of urinary bladder stones in association with bladder tumours in male rats. Moreover, chronic inflammation was significantly increased in the kidney of dosed female rats and is attributed to the administration of melamine.
Acute and chronic inflammation and epithelial hyperplasia of the urinary bladder were found in increased incidence in dosed male mice. However, there was no evidence of bladder tumour development in this species.
In another study (Melnick R.L. et al. 1984a) melamine was administered in the diet to F344 rats or B6C3Fj mice for 103 weeks to determine carcinogenic potential. The dose levels of melamine were 2250 or 4500 ppm for male rats and mice of each sex, and 4500 or 9000 ppm for female rats.
Transitional-cell carcinomas in the urinary bladder of male rats occurred at a significantly higher incidence in the high dose group than in the controls. Seven of the eight male rats with transitional-cell carcinomas of the urinary bladder also had bladder stones. There was a significant association between bladder stones and bladder tumours in male rats fed with high doses of melamine. Urinary bladder tumours were not observed in the low-dose male rat group, while bladder stones were observed in one rat in this group. In female rats, chronic inflammation of the kidney was observed at an increased incidence in both the low and high dose groups.
Discussion
The primary toxicity of melamine is based on the formation of bladder stones. This is also the primary toxic effect for other substances, e.g dimethyl terephthalate and terephthalic acid. In several studies (especially related to melamine and also for the other compounds) it was shown that the irritative stimulation by calculi leads to proliferative lesions in the urinary tract which can result in the formation of tumours in the urinary bladder. As no genotoxic properties were shown for melamine, it can be assumed that the formation of bladder calculi is the only effect which leads to the formation of bladder calculi.
The production of calculi is a high-dose-only phenomenon. Therefore, the extrapolation to humans from the rodent bioassay should be dependent on dose requirements for formation of calculi rather than any type of statistical extrapolation to lower doses.
However, it must be presumed that calculus formation poses some carcinogenic risk to humans. However, the doses frequently required to form calculi are several orders of magnitude greater than the doses expected for human exposure.
Conclusion
Due to melamine induced formation of bladder stones leading to bladder tumours, the NOAEL is considered to be 2250 ppm for males (150 mg/kg bw/day) and 4500 ppm for females (300 mg/kg bw/day).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
Deze website maakt gebruik van cookies om het surfen zo aangenaam mogelijk te maken.